This article has been corrected: The correct author names are given below: Chiara Ancona and Michela Piezzo.

Cazzaniga, M., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M., et al. (2018). Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874) [Altro] [10.18632/oncotarget.26213].

Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874)

Cazzaniga M.
Primo
;
Zambelli A.;
2018

Abstract

This article has been corrected: The correct author names are given below: Chiara Ancona and Michela Piezzo.
Altro
breast
English
2018
9
34639
34640
Scopus ID 2-s2.0-85054264901
Cazzaniga, M., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M., et al. (2018). Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874) [Altro] [10.18632/oncotarget.26213].
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/301381
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
Social impact